VolitionRX (VNRX)
NYSE MKT:VNRX
US Market

VolitionRX (VNRX) Income Statement

435 Followers

VolitionRX Income Statement

Last quarter (Q1 2024), VolitionRX's total revenue was $171.53K, an increase of 43.29% from the same quarter last year. In Q1, VolitionRX's net income was $-8.37M. See VolitionRX’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 702.85K$ 775.30K$ 306.39K$ 90.03K$ 13.43K$ 17.10K
Cost of Revenue
------
Gross Profit
$ 702.86K$ 775.30K$ 306.39K$ 90.03K--
Operating Expense
$ 36.33M$ 36.76M$ 32.09M$ 28.42M$ 20.63M$ 15.90M
Operating Income
$ -35.63M$ -35.99M$ -31.78M$ -28.33M$ -20.61M$ -15.89M
Net Non Operating Interest Income Expense
$ -118.24K$ -128.30K$ -47.82K$ -153.07K$ -80.30K$ -211.16K
Other Income Expense
$ -400.49K$ -438.92K$ -1.23M$ -1.55M$ 293.31K$ -196.96K
Pretax Income
$ -35.52M$ -35.68M$ -30.60M$ -26.94M$ -20.40M$ -16.10M
Tax Provision
---$ 0.00--
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -35.07M$ -35.32M$ -30.27M$ -26.76M$ -20.35M$ -16.10M
Basic EPS
---$ -0.51$ -0.45$ -0.41
Diluted EPS
---$ -0.51$ -0.45$ -0.41
Basic Average Shares
---$ 52.66M$ 45.28M$ 39.18M
Diluted Average Shares
---$ 52.66M$ 45.28M$ 39.18M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 36.33M$ 36.76M$ 32.09M$ 28.42M$ 20.63M$ 15.90M
Interest Expense
----$ 129.80K$ 126.57K
Net Income From Continuing And Discontinued Operation
$ -35.24M$ -35.32M$ -30.27M$ -26.76M$ -20.35M$ -16.10M
Normalized Income
$ -22.76M$ -28.17M--$ -20.65M$ -16.10M
EBIT
$ -35.34M$ -35.46M$ -30.43M$ -26.78M$ -20.27M$ -15.97M
EBITDA
$ -34.57M$ -34.04M$ -29.24M$ -27.69M$ -19.23M$ -15.07M
Currency in USD

VolitionRX Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis